未登录

陶

陶晓军 (Xiaojun Tao)

women and children's hospital of chongqing medical university

H指数:25

被引数:1,669

个人简介

任职于湖南师范大学，副教授，硕士生导师。2011年博士毕业于北京协和医学院（清华大学医学部）。主要研究肿瘤的靶向治疗、纳米制剂的定位释放研究、纳米中药制剂等。主持厅局级课题3项，以第一作者或通讯作者发表SCI论文13篇，中文核心期刊论文5篇。申请发明专利8项，授权4项。获湖北省科技进步奖二等奖，获评2019年湖南师范大学“利君-育人先锋奖”。

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TMEM176B orchestrates intratumoral hierarchy and immunosuppression in hepatocellular carcinoma: Insights from single-cell transcriptomics

TMEM176B调控肝细胞癌肿瘤内分级和免疫抑制：单细胞转录组学的见解

Translational Oncology

IF4.1

2026-08-260

OAAI

Synergistic chemotherapy and phototherapy co-delivery nanoparticle preparation and anti-triple negative breast cancer study

协同化疗与光疗共递送纳米粒制备及抗三阴性乳腺癌研究

IF4.6

2025-08-120

OA

Synergistic anti-triple negative breast cancer study with paclitaxel/ berberine nanoparticle co-delivery system

协同抗三阴性乳腺癌研究：基于紫杉醇/小檗碱纳米粒共递送系统

JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY

IF4.9

2025-05-010

PRE

Longan Aril polysaccharides ameliorate cognitive impairment in AD mice via restoration of the immune phagocytosis of microglia (vol 343, 119464, 2025)

龙眼肉多糖通过恢复小胶质细胞的免疫吞噬作用来改善AD小鼠的认知障碍（卷343，119464，2025）

JOURNAL OF ETHNOPHARMACOLOGY

IF5.4

2025-04-010

PRE

Longan Aril polysaccharides ameliorate cognitive impairment in AD mice via restoration of the immune phagocytosis of microglia

龙眼肉多糖通过恢复小胶质细胞的免疫吞噬作用来改善AD小鼠的认知障碍

JOURNAL OF ETHNOPHARMACOLOGY

IF5.4

2025-03-010

PRE

Effectiveness of a home-based, post-discharge early intervention program for very preterm infants in reducing parental stress: a randomized controlled trial

BMC PUBLIC HEALTH

IF3.6

2024-09-110

OAAI

Tumor Microenvironment Responsive Nanomicelle with Folic Acid Modification Co-Delivery of Doxorubicin/Shikonin for Triple Negative Breast Cancer Treatment

PHARMACEUTICALS

IF4.8

2023-03-016

OAAI

Sorafenib/2800Z Co-Loaded into Cholesterol and PEG Grafted Polylysine NPs for Liver Cancer Treatment

PHARMACEUTICALS

IF4.8

2023-01-137

OAAI

Lactobacillus rhamnosus TR08 Improves Dyslipidemia in Mice Fed with a High Fat Diet by Regulating the Intestinal Microbiota, Reducing Systemic Inflammatory Response, and Promoting Sphingomholipid Metabolism

IF4.6

2022-10-2911

OAAI

Preparation of ICA-loaded mPEG-ICA nanoparticles and their application in the treatment of LPS-induced H9c2 cell damage

NANOSCALE RESEARCH LETTERS

IF4.1

2021-10-172

OAAI

Brain-Targeted Polysorbate 80-Emulsified Donepezil Drug-Loaded Nanoparticles for Neuroprotection

NANOSCALE RESEARCH LETTERS

IF4.1

2021-08-1821

OAAI

Artemisinin Derivatives Inhibit Non-small Cell Lung Cancer Cells Through Induction of ROS-dependent Apoptosis/Ferroptosis

JOURNAL OF CANCER

IF3.2

2021-01-0190

OAAI

Synergistically Enhanced Inhibitory Effects of Pullulan Nanoparticle-Mediated Co-Delivery of Lovastatin and Doxorubicin to Triple-Negative Breast Cancer Cells

普鲁兰纳米颗粒介导的洛伐他汀和阿霉素共递送对三阴性乳腺癌细胞的协同增强抑制作用

NANOSCALE RESEARCH LETTERS

IF4.1

2019-09-1322

OAAI

Prognostic value of biomarkers EpCAM and αB-crystallin associated with lymphatic metastasis in breast cancer by iTRAQ analysis

IF3.4

2019-08-2322

OAAI

Novel Delivery of Mitoxantrone with Hydrophobically Modified Pullulan Nanoparticles to Inhibit Bladder Cancer Cell and the Effect of Nano-drug Size on Inhibition Efficiency

NANOSCALE RESEARCH LETTERS

IF4.1

2018-10-3032

OAAI

Pullulan-Based Nanoparticle-HSA Complex Formation and Drug Release Influenced by Surface Charge

NANOSCALE RESEARCH LETTERS

IF4.1

2018-10-1016

OAAI

Evaluation of the PEG Density in the PEGylated Chitosan Nanoparticles as a Drug Carrier for Curcumin and Mitoxantrone

IF4.3

2018-07-0127

OAAI

Cerasomal Lovastatin Nanohybrids for Efficient Inhibition of Triple-Negative Breast Cancer Stem Cells To Improve Therapeutic Efficacy

Cerasomal洛伐他汀纳米杂化物有效抑制三阴性乳腺癌干细胞以提高治疗效果

ACS APPLIED MATERIALS & INTERFACES

IF8.2

2018-02-1923

PREAI

A self-assembling RNA aptamer-based graphene oxide sensor for the turn-on detection of theophylline in serum

基于自组装RNA适配子的氧化石墨烯传感器用于血清中茶碱的开启检测

BIOSENSORS & BIOELECTRONICS

IF10.5

2016-12-0155

PREAI

Cholesterol-Modified Amino-Pullulan Nanoparticles as a Drug Carrier: Comparative Study of Cholesterol-Modified Carboxyethyl Pullulan and Pullulan Nanoparticles

IF4.3

2016-09-0831

OAAI